Member Info for wozzer70

The Guident IPO is the first domino. But when it falls, the ripple effects will lead to a few surprises. Not everything has been revealed yet, and what’s in the works is bigger than most people realize. 🌪️🚀

I’ve laid out the monetization roadmap on my profile. Most will ignore it because it's easier to be rude than it is to be diligent. But for the few who want to understand how the value unlocks, the work is already done for you.

Onwards and upwards 👊 🎯

MicroSalt, Lucyd, and GenIP already have market valuations.

The portfolio is no longer theoretical - most of the assets already trade independently.

Guident is the final major asset still waiting for a public market valuation.

Once Guident has a NASDAQ price, Tekcapital moves from a portfolio partly priced by the market to one where the majority of value has a visible reference point.

That’s usually when holding-company discounts begin to narrow.

Guident doesn’t create the NAV - it gives the market a reason to recognise it.

Tekcapital only really makes sense once you look at the full portfolio and the liquidity model together.

Viewed in isolation, pieces can look ordinary.

Viewed as a system, the strategy becomes clear.

Once Guident (ticker: GDNT) has its own NASDAQ price tag, one of TEK’s major assets will be independently valued in the market.

That clarity is often where rerates begin.

Tekcapital is not a single-asset investment. It is a portfolio strategy built around developing IP companies and bringing them to market.

Understanding the structure is key.

Ingredient 1 – Patience

Tekcapital builds value over time through commercialisation and IPOs.

Rerates follow milestones, not message board sentiment.

Ingredient 2 – NAV Foundation

Audited NAV is around 26p versus a share price near 8p.

The discount is real.

The investment case starts with recognising the gap.

Ingredient 3 – The Portfolio

Tekcapital holds multiple growth companies:

MicroSalt

Lucyd

GenIP

Guident

Each progresses on its own timeline.

Value is created across the portfolio, not from a single asset.

Ingredient 4 – The IPO Model

Tekcapital creates value by listing portfolio companies.

Lucyd – Listed

MicroSalt – Listed

GenIP – Listed

Guident – Preparing for Nasdaq

Listings establish market valuations and drive Tekcapital rerates.

Ingredient 5 – Volatility

Small-cap IP companies move in cycles.

Quiet periods are normal.

Execution comes in phases.

Ingredient 6 – Discipline

Buying during uncertainty requires conviction.

Holding through noise requires understanding.

Facts matter more than sentiment.

Final Course – The Rerate

Portfolio listings create independent market valuations.

That is how the NAV discount closes.

Some focus on short-term noise.

Others focus on long-term value

TEK’s MAX chart shows a classic wedge pattern, coiled at key historical support (~7.5p–8p). This zone has been the bedrock for years, and the current barcoding suggests the spring is fully compressed.

Rerate Roadmap:

Trigger: Guident’s NASDAQ IPO could ignite the breakout.

Necklines: Resistance at 10.5p, 12p, 15p — confirmation points for the trend.

Clustered Resistance: Historical supply zones at 20p & 35p need clearing to approach the ~26p audited NAV.

IPO Pop Factor:

A listing is a high-velocity event. Structural rerate can clear multiple necklines quickly as the market recalibrates Tekcapital’s value.

The Stage Is Set - IPO Is The Spark 🧨

Chart -

https://docs.google.com/document/d/12AXekfMiPgzH3NpokvrMCCTe8l0QNIoxjFLNspCK61w/edit?usp=drivesdk

Tekcapital – Facts Over Noise

Audited NAV: ~26p vs share price: ~8p. The gap is real.

Portfolio in motion: MicroSalt, Lucyd, GenIP, SALT, Guident. Growth and IP everywhere.

Guident Nasdaq listing = post-IPO rerate trigger. Market reference point imminent.

Filings complete. Companies executing. Strategy unfolding.

Some watch the noise. Others watch the facts. The difference is obvious.

Facts Don’t Need Trust!

Numbers, filings, and audited NAVs speak louder than opinions.

Tekcapital’s £77M+ NAV and the pipeline of MicroSalt, Lucyd, GenIP, and Guident aren’t a matter of trust - they’re a matter of record.

Those paying attention will see the progress. Those yelling (BS) from the sidelines… remain irrelevant.

Perspective vs Panic

Selling insight-free opinions isn’t investing. Tekcapital’s NAV isn’t a rumor, it’s published. MicroSalt, Lucyd, GenIP, and Guident are all moving forward, audited, and building value. Waiting for a “miracle” is a choice; positioning ahead of milestones is strategy.

The market rewards execution, not fear.

It’s fascinating how much energy some put into arguing against a portfolio they haven’t analyzed. Meanwhile, Tekcapital is quietly building companies, filing audits, and preparing liquidity events. MicroSalt, Lucyd, GenIP, and Guident aren’t waiting for forum approval - they’re advancing regardless. The market eventually rewards substance, not BS.

The NAV gap is the opportunity.

As Guident progresses toward IPO, MicroSalt scales, GenIP compounds high-margin growth, and Lucyd expands distribution, Tekcapital’s value will become harder to ignore.

This isn’t about waiting for perfection - it’s about recognising value before the market does.

£49k lifted at 8.2p after the early sells were cleared - looks like someone wanted stock

Multiple Cash-Generation Options

A listed Guident, plus an already-listed MicroSalt, Lucyd and spun-out GenIP, gives Tekcapital something it hasn’t had before: multiple cash-generation options. These assets will not only fund organic growth but also enable Tek to reinvest in future innovations and potentially fund special returns. The IPO is just the beginning of a long-term strategy for value creation.

The interesting part here is that Guident is currently being valued by the market at close to zero inside Tekcapital, despite patented autonomous vehicle technology and prior independent IP valuation work around $35m.

With the Nasdaq listing progressing, that disconnect won’t last forever. IPOs have a way of forcing the market to put a real number on assets that were previously ignored.

At ~8p, TEK looks less like a single investment and more like a portfolio where Guident alone could justify a meaningful part of the current market cap.

The groundwork is already in place - assets established and an audited NAV of ~26p versus an ~8p share price.

From here, it becomes less about opinion and more about execution. NAV gaps typically begin to close when the market is given a clear crystallisation point. Guident’s Nasdaq listing is intended to provide exactly that.

History shows some investors wait for the RNS confirmation, while others position at multi-year support before it arrives. One group catches the move - the other chases it.

The MAX chart shows 8p isn’t a random level - it’s long-term support that has held repeatedly over the years.

Recent price action is building a tight base around 8–8.5p, suggesting consolidation rather than weakness.

There’s also a clear open gap around 10.5–11p. Once a base is established, gaps like this often get revisited.

Short-term noise aside, the chart shows a stock sitting on multi-year support while the fundamentals continue to develop.

Guident’s Nasdaq listing looks less like an event and more like the starting point of a broader market reappraisal.

NAV is only a number on paper until the market is given a reason to recognise it -Guident will potentially be that moment. ✨

Some bears love to claim: “Buy SALT, forget Tekcapital.” Let’s step into that fantasy for a second:

Tekcapital is more than one company - MicroSalt, GenIP, Lucyd, and Guident form a connected ecosystem. SALT alone is a single tile in a much bigger mosaic.

NAV (~$77m) reflects the value of all assets. Tekcapital shareholders are positioned to benefit from the growth and liquidity of the entire portfolio, not just one component.

Guident’s Nasdaq IPO is the starting gun for NAV realisation. The market will begin to recognise value systematically, asset by asset, creating a rerate that a SALT-only focus simply ignores.

This is strategic, deliberate, and evidence-based. Tekcapital isn’t waiting for hype - it’s converting private IP into public value.

Meanwhile, those stuck on one small piece miss the optionality and compounding upside.

In short: Tekcapital plays the long game with multiple levers of value creation, while the bear logic is firmly in the shallow end and stuck in the (VOID)

The Naysayers Thrive On Doubt, But Tekcapital Thrives on Data and Innovation

While the bears cling to their short-term doubts, stuck in their void, Tekcapital continues to build with data, innovation, and long-term vision. The more the bears bark, the clearer it becomes - they’re out of their depth in a market that rewards innovation over noise. 🎶

If Tekcapital was worthless, nobody would spend this much time trying to discredit it.

Silence usually follows irrelevance.

Onwards and upwards 🍹

The “Liquidity Event”

Tekcapital’s model has always been the same:

Acquire IP ➡️ Build companies ➡️ List ➡️ Monetise ➡️ Repeat.

MicroSalt listed.

GenIP spun out.

Guident progressing.

The strategy isn’t theory — it’s already happening.

The “NAV Reality”

The interesting part about Tek is simple:

~8p share price.

~26p audited NAV.

Either the assets are real — or they aren’t.

The filings say they are.

The market will decide the rest.

Cheers 🍹

interesting to see so much discussion about “silence.”

in a nasdaq ipo process, silence isn’t a problem — it’s compliance. the quiet period exists for a reason, and filings move the process forward whether bulletin boards approve or not.

meanwhile the numbers remain unchanged.

microsalt targeting ~$7m revenue in 2026.

genip scaling.

lucyd growing.

guident advancing through the sec process.

that’s the portfolio behind the ~26p audited nav.

no superlatives required.

no ai required.

just filings and a calculator.

the 8p placing is being absorbed.

the assets remain.

the process continues.

back to my ****tail 🍹